The National Heart, Lung, and Blood Institute (NHLBI) has 3 targeted funding opportunities with deadlines in February. It’s also not too early to start preparing for the April 5 Omnibus solicitation deadline. Check your registrations (SAM must be renewed annually!) and reach out to discuss your project.
For questions about the NHLBI SBIR/STTR programs, contact Small Business Coordinator Jennifer Shieh, PhD at NHLBI_SBIR@mail.nih.gov
Human Cellular Models for Predicting Individual Responses to CFTR-Directed Therapeutics— Due February 9
For the development and validation of novel in vitro human cell-based tools for predicting the responses of individual patients to cystic fibrosis transmembrane conductance regulator (CFTR)-directed therapeutics for cystic fibrosis lung disease.
SBIR: RFA-HL-15-027 STTR: RFA-HL-15-026
For questions about these funding opportunities, contact:
Robert Smith, PhD, robert.smith4@nih.gov
Program Director, Division of Lung Diseases
Development of a Microfluidic Platform for Blood Testing in Neonatal & Pediatric Patients— Due February 10 (Phase II only)
For the development of microfluidic devices to analyze blood for factors related to the thrombotic, transfusion, and/or hemostatic status of pediatric/neonatal patients.
SBIR—Phase II only: RFA-HL-14-026
This application must be based on an awarded SBIR or STTR-funded Phase I project.
For questions about this funding opportunity, contact:
Ronald Warren, PhD, rwarren@nhlbi.nih.gov
Program Director, Division of Blood Diseases and Resources
Stem Cell-Derived Blood Products for Therapeutic Use: Technology Improvement— Due February 20
For tools and technologies that enable further advances in the manufacturing process to produce safe and functional blood and platelet products at reduced costs.
SBIR: RFA-HL-15-030 STTR: RFA-HL-15-029
Slides from the January 8 webinar are available—please send a request to NHLBI_SBIR@mail.nih.gov.
For questions about these funding opportunities, contact:
Shimian Zou, PhD, shimian.zou@nih.gov
Program Director, Division of Blood Diseases and Resources
John Thomas, PhD, thomasj@nhlbi.nih.gov
Program Director, Division of Blood Diseases and Resources